Ekso Bionics Holdings, Inc. Common Stock
EKSOEkso Bionics Holdings, Inc. develops and manufactures wearable robotic exoskeletons designed to assist mobility for patients with neurological or orthopedic conditions. The company's exoskeletons are used in rehabilitation hospitals, clinical settings, and by industrial workers, aiming to enhance mobility, strength, and endurance. Founded in 2005, Ekso Bionics focuses on innovative robotic systems that support physical therapy and improve quality of life.
Company News
Applied Digital's stock surged 18% after reporting 250% revenue growth and announcing advanced talks for 900 megawatts of data center capacity with major cloud providers. While the company benefits from AI infrastructure demand and cheap power access, its capital-intensive business model, negative free cash flow of $899.4 million, and 250% year-o...
Applied Digital (APLD) has surged to the 99th percentile momentum score following strong Q2 earnings with 250% revenue growth to $126.6 million. The company announced plans to spin off its GPU Cloud business into a standalone entity called ChronoScale through a merger with EKSO Bionics, expected to close in H1 2026. APLD is leveraging natural gas...
Halper Sadeh LLC, an investor rights law firm, is investigating four companies for potential violations of federal securities laws and breaches of fiduciary duties related to their merger and acquisition transactions. The firm is seeking increased consideration for shareholders and additional disclosures regarding the proposed deals.
Applied Digital is set to report Q2 2026 earnings with analysts expecting $89.76M in revenue (40%+ YoY growth) driven by its AI data center operations and CoreWeave partnership. The company is expected to report a $0.10 loss per share while benefiting from operating leverage. Key focus areas include CoreWeave's 400 MW lease expansion at Ellendale...
Investor rights law firm Halper Sadeh LLC is investigating four companies for potential federal securities law violations and breaches of fiduciary duties related to their merger and acquisition transactions. The firm is seeking increased consideration for shareholders and additional disclosures, and is offering contingent fee representation.
